Renalytix Plc (FRA:2O9)

Germany flag Germany · Delayed Price · Currency is EUR
0.0715
-0.0005 (-0.69%)
Last updated: Dec 4, 2025, 3:29 PM CET
-5.92%
Market Cap 33.78M
Revenue (ttm) 2.55M
Net Income (ttm) -17.37M
Shares Out n/a
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 816
Average Volume n/a
Open 0.0720
Previous Close 0.0720
Day's Range 0.0710 - 0.0720
52-Week Range 0.0565 - 0.1410
Beta n/a
RSI 38.18
Earnings Date Dec 17, 2025

About Renalytix

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. The company’s products are used in kidney disease diagnosis and prognosis, cl... [Read more]

Industry Prepackaged Software
Founded 2018
Country United Kingdom
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2O9
Full Company Profile

Financial Performance

In 2025, Renalytix's revenue was $3.00 million, an increase of 30.43% compared to the previous year's $2.30 million. Losses were -$20.40 million, -55.16% less than in 2024.

Financial numbers in USD Financial Statements

News

There is no news available yet.